ONGLYZA

Welcome to the Brand page for “ONGLYZA”, which is offered here for The mark consists of the word onglyza and four stylized lines above the trademark.;pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “ONGLYZA” is believed to be currently owned by “BRISTOL-MYERS SQUIBB COMPANY”.

Owner:
BRISTOL-MYERS SQUIBB COMPANY
Owner Details
Description:
The mark consists of the word ONGLYZA and four stylized lines above the trademark.;Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies;Color is not claimed as a feature of the mark.;
Categories: TRADEMARK